Literature DB >> 17355321

Inhibition of vasopressin V1b receptor translation by upstream open reading frames in the 5'-untranslated region.

C Rabadan-Diehl1, A Martínez, S Volpi, S Subburaju, G Aguilera.   

Abstract

The 5'-UTR of the vasopressin V1b receptor (V1bR) mRNA contains small open reading frames (ORF) located upstream (u) of the main ORF encoding the V1bR. The ability of the three proximal uORFs to be translated into peptides and their influence on V1bR translation was examined using fusion constructs of uORFs and V5 epitope, or ATG/ATA uORF mutations in the V1bR cDNA. In vitro translation and western blot analysis after transfection of uORF1-V5 or uORF2-V5 into cells revealed that uORF1 can be translated. As predicted by computer analysis, in vitro translation using a rabbit reticulocyte/canine microsome system, immunohistochemistry and western blot in membranes of transfected cells with uORF1-V5 revealed translocation of the uORF1 peptide into membrane fractions. In vitro translation of V1bR cDNA with mutations of the two uORFs proximal to the initiating methionine, uORFs 1 and 2 (Mut 1-2), or uORF2 (Mut 2) showed significantly increased translation of a 46 kDa band corresponding to the V1bR, compared with wild-type (WT) V1bR, an effect that was attenuated by cotranslation of uORF1-V5. Consistently, VP-induced inositol phosphate formation was higher in Chinese hamster ovay cells transfected with Mut 1-2 than with WT V1bR. Immunohistochemical and western blot analysis, using an antibody against uORF1, revealed peptide immunoreactivity in rat pituitary but not in liver. Pituitary uORF immunoreactivity increased following glucocorticoid administration. The present study shows that uORFs in the 5'-UTR of the V1bR mRNA inhibit V1bR translation, and suggests that translation of a 38-amino acid membrane peptide encoded by uORF1 exerts tonic inhibition of V1bR translation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17355321     DOI: 10.1111/j.1365-2826.2007.01533.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  7 in total

Review 1.  A 5'-upstream short open reading frame encoded peptide regulates angiotensin type 1a receptor production and signalling via the β-arrestin pathway.

Authors:  Gina L C Yosten; Jun Liu; Hong Ji; Kathryn Sandberg; Robert Speth; Willis K Samson
Journal:  J Physiol       Date:  2015-10-13       Impact factor: 5.182

2.  Evidence that vasopressin V1b receptors mediate the transition to excessive drinking in ethanol-dependent rats.

Authors:  Scott Edwards; Miguel Guerrero; Ola M Ghoneim; Edward Roberts; George F Koob
Journal:  Addict Biol       Date:  2011-02-11       Impact factor: 4.280

3.  Selective inhibition of angiotensin receptor signaling through Erk1/2 pathway by a novel peptide.

Authors:  Jun Liu; Gina L C Yosten; Hong Ji; Dan Zhang; Wei Zheng; Robert C Speth; Willis K Samson; Kathryn Sandberg
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-02-12       Impact factor: 3.619

4.  Structural and functional evolution of the P2Y(12)-like receptor group.

Authors:  Torsten Schöneberg; Thomas Hermsdorf; Eva Engemaier; Kathrin Engel; Ines Liebscher; Doreen Thor; Klaas Zierau; Holger Römpler; Angela Schulz
Journal:  Purinergic Signal       Date:  2007-09-06       Impact factor: 3.765

5.  uORFdb--a comprehensive literature database on eukaryotic uORF biology.

Authors:  Klaus Wethmar; Adriano Barbosa-Silva; Miguel A Andrade-Navarro; Achim Leutz
Journal:  Nucleic Acids Res       Date:  2013-10-24       Impact factor: 16.971

6.  Mechanisms underlying the increased plasma ACTH levels in chronic psychosocially stressed male mice.

Authors:  Andrea M Füchsl; Dominik Langgartner; Stefan O Reber
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

Review 7.  A perspective on mammalian upstream open reading frame function.

Authors:  Joanna Somers; Tuija Pöyry; Anne E Willis
Journal:  Int J Biochem Cell Biol       Date:  2013-04-25       Impact factor: 5.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.